Bribes common when vendors sell imaging equipment to Chinese hospitals

Leading imaging vendors regularly bribe government officials in China to get their products in area hospitals, according to an in-depth report from the New York Times.

New York Times reporters Alexandra Stevenson and Sui-Lee Wee interviewed numerous insiders and reviewed dozens of court cases and internal documents. Employees of General Electric, Philips and Siemens all testified in court that they had bribed hospital officials. The court cases, however, were not aimed at punishing the imaging vendors—they were designed to take on the Chinese officials who accept these bribes.

And who suffers the most due to the repeated bribes? According to Stevenson and Wee, it’s the same patients the equipment was designed to help.

“China’s nearly 1.4 billion people ultimately bear the cost of the corruption,” according to the report. “Salespeople inflated prices for equipment to fund bribes and kickbacks, the Chinese court documents show. They also refused to undercut one another’s pricing, the documents showed, inflating prices for hospitals by 50 percent or even more.”

Click below to read the full story from the New York Times.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.